A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

May 30, 2028

Study Completion Date

May 30, 2028

Conditions
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Interventions
DRUG

Vutrisiran

Vutrisiran administered SC q3M

Trial Locations (74)

10029

Clinical Trial Site, New York

10032

Clinical Trial Site, New York

19104

Clinical Trial Site, Philadelphia

20010

Clinical Trial Site, Washington D.C.

21287

Clinical Trial Site, Baltimore

27710

Clinical Trial Site, Durham

37232

Clinical Trial Site, Nashville

43214

Clinical Trial Site, Columbus

44195

Clinical Trial Site, Cleveland

46202

Clinical Trial Site, Indianapolis

55905

Clinical Trial Site, Rochester

60201

Clinical Trial Site, Chicago

60637

Clinical Trial Site, Chicago

63130

Clinical Trial Site, St Louis

66103

Clinical Trial Site, Kansas City

68198

Clinical Trial Site, Omaha

75246

Clinical Trial Site, Dallas

84132

Clinical Trial Site, Salt Lake City

85054

Clinical Trial Site, Phoenix

90048

Clinical Trial Site, West Hollywood

92037

Clinical Trial Site, San Diego

94305

Clinical Trial Site, Stanford

02115

Clinical Trial Site, Boston

02215

Clinical Trial Site, Boston

Unknown

Clinical Trial Site, Buenos Aires

Clinical Trial Site, Córdoba

Clinical Trial Site, Rosario

Clinical Trial Site, Vienna

Clinical Trial Site, Aalst

Clinical Trial Site, Anderlecht

Clinical Trial Site, Dendermonde

Clinical Trial Site, Ghent

Clinical Trial Site, Hasselt

Clinical Trial Site, Leuven

Clinical Trial Site, Liège

Clinical Trial Site, Roeselare

Clinical Trial Site, Ribeirão Preto

Clinical Trial Site, Rio de Janeiro

Clinical Trial Site, São Paulo

Clinical Trial Site, Prague

Clinical Trial Site, Aarhus

Clinical Trial Site, Copenhagen

Clinical Trial Site, Odense

Clinical Trial Site, Créteil

Clinical Trial Site, Marseille

Clinical Trial Site, Paris

Clinical Trial Site, Rennes

Clinical Trial Site, Toulouse

Clinical Trial Site, Bologna

Clinical Trial Site, Florence

Clinical Trial Site, Pavia

Clinical Trial Site, Groningen

Clinical Trial Site, Maastricht

Clinical Trial Site, Utrecht

Clinical Trial Site, Oslo

Clinical Trial Site, Creixomil

Clinical Trial Site, Lisbon

Clinical Trial Site, Porto

Clinical Trial Site, Viseu

Clinical Trial Site, Barcelona

Clinical Trial Site, Bilbao

Clinical Trial Site, Llobregat

Clinical Trial Site, Majadahonda

Clinical Trial Site, Málaga

Clinical Trial Site, Taipei

Clinical Trial Site, Bellshill

Clinical Trial Site, Birmingham

Clinical Trial Site, Cardiff

Clinical Trial Site, Hexham

Clinical Trial Site, London

Clinical Trial Site, Manchester

413 45

Clinical Trial Site, Gothenburg

171 76

Clinical Trial Site, Solna

901 85

Clinical Trial Site, Umeå

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY